Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.
Carbognin L, Pilotto S, Milella M, Vaccaro V, Brunelli M, Caliò A, Cuppone F, Sperduti I, Giannarelli D, Chilosi M, Bronte V, Scarpa A, Bria E, Tortora G. Carbognin L, et al. Among authors: cuppone f. PLoS One. 2015 Jun 18;10(6):e0130142. doi: 10.1371/journal.pone.0130142. eCollection 2015. PLoS One. 2015. PMID: 26086854 Free PMC article.
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis.
Bria E, Milella M, Cuppone F, Novello S, Ceribelli A, Vaccaro V, Sperduti I, Gelibter A, Scagliotti GV, Cognetti F, Giannarelli D. Bria E, et al. Among authors: cuppone f. Ann Oncol. 2011 Oct;22(10):2277-85. doi: 10.1093/annonc/mdq742. Epub 2011 Feb 16. Ann Oncol. 2011. PMID: 21325444 Free PMC article. Review.
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice.
Caccese M, Ferrara R, Pilotto S, Carbognin L, Grizzi G, Caliò A, Brunelli M, Cuppone F, Petraglia S, Scarpa A, Tortora G, Bria E. Caccese M, et al. Among authors: cuppone f. Expert Opin Pharmacother. 2016 Dec;17(17):2253-2266. doi: 10.1080/14656566.2016.1242578. Epub 2016 Oct 8. Expert Opin Pharmacother. 2016. PMID: 27682212 Review.
Adjuvant chemotherapy for non-small cell lung cancer.
Bria E, Cuppone F, Cecere FL, Milella M, Nisticò C, Cognetti F, Terzoli E. Bria E, et al. Among authors: cuppone f. J Thorac Oncol. 2007 May;2(5 Suppl):S7-11. doi: 10.1097/01.JTO.0000268633.87529.75. J Thorac Oncol. 2007. PMID: 17457237 Free article. Review.
Cardiotoxicity and incidence of brain metastases after adjuvant trastuzumab for early breast cancer: the dark side of the moon? A meta-analysis of the randomized trials.
Bria E, Cuppone F, Fornier M, Nisticò C, Carlini P, Milella M, Sperduti I, Terzoli E, Cognetti F, Giannarelli D. Bria E, et al. Among authors: cuppone f. Breast Cancer Res Treat. 2008 May;109(2):231-9. doi: 10.1007/s10549-007-9663-z. Epub 2007 Jul 19. Breast Cancer Res Treat. 2008. PMID: 17638068 Review.
44 results